A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for Non-Muscle Invasive Bladder Neoplasms
22 locations incl. Sun City
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06919965·Phase 3·Recruiting